Parkinson’s Disease Clinical Trial Solutions from Cogstate

While motor function is a hallmark of Parkinson’s disease (PD) clinical trials, drug development efforts are increasingly addressing additional aspects of the disease including cognitive impairment, as patients note these symptoms as being among the most impactful aspects of living with PD.

Cogstate helps sponsors gather high quality data in PD trials by providing sensitive and reliable digital cognitive assessments, as well as supporting rater training, central monitoring, and eCOA for the full range of clinical outcome assessments including motor function, quality of life, cognition, depression, suicidality, symptom severity, and sleep.

Please fill out the form below to download the fact sheet and learn more about we support PD clinical trials globally.

Back to Fact Sheets